-+ 0.00%
-+ 0.00%
-+ 0.00%

*Ovid Therapeutics: Carter Succeeds Jeffrey Rona, Who Will Remain Long-Term Advisor Through 2027 >OVID

Dow Jones·07/08/2026 11:14:00

Please log in to view news